We are live on ! Find out more
FCMV

Foresite Capital Management VI Portfolio holdings

AUM $460M
1-Year Est. Return 261.77%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+261.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$460M
AUM Growth
+$129M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

1
+$11.4M
2
+$9.47M
3
+$8.61M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$7.18M
5
GHRS icon
GH Research
GHRS
+$4.84M

Top Sells

1
+$52.9M
2
+$15.4M
3
+$142K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$5.08B
$150M 32.67%
2,221,474
ALMS
2
Alumis Inc
ALMS
$2.66B
$93.6M 20.33%
4,247,670
CNTA
3
Centessa Pharmaceuticals
CNTA
$6.14B
$54.2M 11.77%
1,364,019
CRVS icon
4
Corvus Pharmaceuticals
CRVS
$938M
$26.8M 5.82%
1,831,233
+450,000
DNLI icon
5
Denali Therapeutics
DNLI
$3.34B
$23.2M 5.05%
1,209,971
+209,971
AGIO icon
6
Agios Pharmaceuticals
AGIO
$1.72B
$17.8M 3.86%
525,000
-5,000
VSTM icon
7
Verastem
VSTM
$330M
$16.7M 3.62%
3,146,631
+11,511
KYMR icon
8
Kymera Therapeutics
KYMR
$6.82B
$12.2M 2.65%
146,332
NERV icon
9
Minerva Neurosciences
NERV
$218M
$12M 2.6%
+1,986,600
CLDX icon
10
Celldex Therapeutics
CLDX
$2.3B
$10M 2.18%
+315,913
ATAI icon
11
AtaiBeckley Inc
ATAI
$1.4B
$9.73M 2.12%
2,750,000
HNGE
12
Hinge Health
HNGE
$5.01B
$8.5M 1.85%
220,400
+85,400
CRNX icon
13
Crinetics Pharmaceuticals
CRNX
$3.62B
$7.7M 1.67%
+212,010
OKUR
14
OnKure Therapeutics
OKUR
$172M
$5.99M 1.3%
+1,445,783
JBIO
15
Jade Biosciences
JBIO
$929M
$4.5M 0.98%
+320,000
GHRS icon
16
GH Research
GHRS
$1.4B
$4.44M 0.96%
+315,492
ZURA icon
17
Zura Bio
ZURA
$340M
$2.68M 0.58%
+450,000
NTRA icon
18
Natera
NTRA
$31B
– –
-67,356
RAPT
19
DELISTED
RAPT Therapeutics
RAPT
– –
-1,562,500